Assignee
JW PHARMACEUTICAL CORP
KR·8 granted patents·6 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
14 records- 0189US2026070923A1Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compoundJW PHARMACEUTICAL CORP·Filed 2025·Application pending·0 cites
- 0280US12103938B2Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compoundJW PHARMACEUTICAL CORP·Filed 2023·Granted Oct 1, 2024·0 cites·8 claims
- 0380US12030895B2Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compoundJW PHARMACEUTICAL CORP·Filed 2023·Granted Jul 9, 2024·0 cites·2 claims
- 0479US12497410B2Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compoundJW PHARMACEUTICAL CORP·Filed 2022·Granted Dec 16, 2025·0 cites·3 claims
- 0576US11866448B2Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compoundJW PHARMACEUTICAL CORP·Filed 2022·Granted Jan 9, 2024·0 cites·6 claims
- 0664US2026085071A1Novel crystalline form of 1-(8-bromopyrido[2,3- e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-nmethylazetidin- 3-amineJW PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 0758US2020207784A1Method For Preparing Heterocyclic Derivative Compound, Composition Containing Same Compound, And Hydrate of Same CompoundJW PHARMACEUTICAL CORP·Filed 2018·Application pending·0 cites
- 0857US2024166648A1Novel Crystalline Form Of 1-(8-Bromopyrido[2,3-E][1,2,4]triazolo[4,3-A]pyrazin-4-Yl)-Nmethylazetidin-3-Amine Hydrogen Sulfate MonohydrateJW PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 0944US9840506B2Crystal of doripenem, and preparation method thereforJW PHARMACEUTICAL CORP·Filed 2015·Granted Dec 12, 2017·0 cites·14 claims
- 1042US11633409B2Solid preparation comprising dutasteride and method for preparing sameJW PHARMACEUTICAL CORP·Filed 2018·Granted Apr 25, 2023·0 cites·12 claims
- 1141US2024173187A1IncubatorJW PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 1238US12583852B2Heterocycle derivativeJW PHARMACEUTICAL CORP·Filed 2019·Granted Mar 24, 2026·0 cites·6 claims
- 1337US2024300949A1Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hemisuccinateJW PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 1435US9879038B2Salt of tenofovir disoproxilJW PHARMACEUTICAL CORP·Filed 2015·Granted Jan 30, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when JW PHARMACEUTICAL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →